Smithfield Trust’s Takeda Pharmaceutical TAK Stock Holding History

Smithfield Trust’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33K	Hold	2,108	–	–	﹤0.01%	691
2026 Q1	$36K	Sell	2,108 -4	-0.2%	-$70	﹤0.01%	651
2025 Q4	$31K	Buy	2,112 +243	+13%	+$3.47K	﹤0.01%	677
2025 Q3	$27K	Hold	1,869	–	–	﹤0.01%	682
2025 Q2	$28K	Hold	1,869	–	–	﹤0.01%	665
2025 Q1	$28K	Sell	1,869 -69	-4%	-$967	﹤0.01%	651
2024 Q4	$27K	Sell	1,938 -1,490	-43%	-$20.5K	﹤0.01%	671
2024 Q3	$49K	Buy	3,428 +1,490	+77%	+$21.1K	﹤0.01%	563
2024 Q2	$26K	Hold	1,938	–	–	﹤0.01%	652
2024 Q1	$27K	Hold	1,938	–	–	﹤0.01%	662
2023 Q4	$28K	Sell	1,938 -276	-12%	-$3.92K	﹤0.01%	642
2023 Q3	$34K	Hold	2,214	–	–	﹤0.01%	590
2023 Q2	$35K	Hold	2,214	–	–	﹤0.01%	605
2023 Q1	$37K	Hold	2,214	–	–	﹤0.01%	574
2022 Q4	$34K	Hold	2,214	–	–	﹤0.01%	572
2022 Q3	$29K	Hold	2,214	–	–	﹤0.01%	588
2022 Q2	$32K	Hold	2,214	–	–	﹤0.01%	600
2022 Q1	$32K	Hold	2,214	–	–	﹤0.01%	621
2021 Q4	$30K	Hold	2,214	–	–	﹤0.01%	643
2021 Q3	$36K	Hold	2,214	–	–	﹤0.01%	612
2021 Q2	$37K	Hold	2,214	–	–	﹤0.01%	596
2021 Q1	$40K	Hold	2,214	–	–	﹤0.01%	591
2020 Q4	$40K	Hold	2,214	–	–	﹤0.01%	564
2020 Q3	$39K	Hold	2,214	–	–	﹤0.01%	543
2020 Q2	$40K	Hold	2,214	–	–	﹤0.01%	524
2020 Q1	$34K	Sell	2,214 -669	-23%	-$12.1K	﹤0.01%	503
2019 Q4	$57K	Sell	2,883 -503	-15%	-$9.62K	0.01%	502
2019 Q3	$59K	Sell	3,386 -840	-20%	-$14.5K	0.01%	501
2019 Q2	$75K	Buy	4,226 +503	+14%	+$9.15K	0.01%	458
2019 Q1	$76K	Buy	+3,723	New	+$74.9K	0.01%	439

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Smithfield Trust's TAK Position: Q2 2026 in Review

Smithfield Trust held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 2,108 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #691.

Smithfield Trust first reported a position in TAK in Q1 2019 and has held it in 30 quarters since. The position peaked at $76K in Q1 2019. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Smithfield Trust held 2,108 shares of Takeda Pharmaceutical worth $33K as of Q2 2026.
Smithfield Trust left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Smithfield Trust's portfolio in Q2 2026, its #691 holding.
Smithfield Trust first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
Smithfield Trust's Takeda Pharmaceutical position peaked at $76K in Q1 2019.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Smithfield Trust's 13F filing for Q2 2026, filed 5 Aug 2026.